首页> 外文期刊>Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer >The Surgery after... retroperitoneal lymph node dissection and surgery of the residual masses after chemotherapy for advanced testicular cancer
【24h】

The Surgery after... retroperitoneal lymph node dissection and surgery of the residual masses after chemotherapy for advanced testicular cancer

机译:手术后……剩余的解剖和手术质量先进的睾丸癌的化疗后

获取原文
获取原文并翻译 | 示例
           

摘要

Thirty-six cases of retroperitoneal lymph node dissections for residual mass after chemotherapy for testicular cancer are reported. In a reference center, the recruitment is modified by the severity of the situations related to very big masses, tumors of poor prognosis and resistant tumors. Lymph node dissection is often atypical and surgery of metastatic residual masses is frequent (13 operations). The 8-year global survival remains stable, over 90%. The 5-year cumulated risk of recurrence is 20%, but these situations can be overtaken.
机译:36例腹膜后淋巴结解剖后的剩余质量化疗睾丸癌的报道。修改参考中心,招聘非常情况的严重程度相关大群众,肿瘤的预后不良抗肿瘤。转移剩余的非典型和手术群众频繁(13操作)。全球的生存依然稳定,超过90%。5年累积复发的风险是20%,但是这些情况可以取代。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号